AstraZeneca PLC banner

AstraZeneca PLC
XBER:ZEG

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
XBER:ZEG
Watchlist
Price: 156.8 EUR Market Closed
Market Cap: €242.9B

Wall St Price Targets

ZEG Price Targets Summary
AstraZeneca PLC

Wall Street analysts forecast ZEG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZEG is 209.93 EUR with a low forecast of 143.26 EUR and a high forecast of 245.14 EUR.

Lowest Forecast
Price Target
143.26 EUR
9% Downside
Average Forecast
Price Target
209.93 EUR
34% Upside
Highest Forecast
Price Target
245.14 EUR
56% Upside
AstraZeneca PLC Competitors:
Price Targets
6657
Energenesis Biomedical Co Ltd
27% Upside
FCBC
First Community Bankshares Inc
3% Upside

Revenue
Forecast

6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 5%.

Gross Profit
Forecast

6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
6% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 5%.

Operating Income
Forecast

4% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-37%
Average Miss
4% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-37%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 11%.

Pre-Tax Income
Forecast

4% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss
4% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 26%.

Net Income
Forecast

4% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss
4% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ZEG's stock price target?
Price Target
209.93 EUR

According to Wall Street analysts, the average 1-year price target for ZEG is 209.93 EUR with a low forecast of 143.26 EUR and a high forecast of 245.14 EUR.

What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 5%.

What is the Gross Profit forecast for AstraZeneca PLC?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 5%.

What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 11%.

What is the Pre-Tax Income forecast for AstraZeneca PLC?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 26%.

What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett